EM
Editas Medicine Inc
🇺🇸XNAS.EDITUnited StatesHealthcare
$2.67USDup +0.04 (+1.52%)OpenDelayed2:21 PM
Price$2.67+0.04 (+1.52%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US28106W1036
- CUSIP
- 28106W103
Company
- Employees
- 87
- Headquarters
- Cambridge, United States
- CEO
- Dr. Gilmore O'Neill M.D.
Market
- Shares outstanding
- 153.6M
- Market cap
- $410.06M
Key dates
- Next earnings
- Nov 9, 2026
Highlights
- Market cap
- $400.84M
- EPS LTM
- -$0.48calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -5.55calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $47.01M+20.83%up year on year
- Net income
- -$73.95M+68.78%up year on year
- Gross margin
- 55.19%+139.7%up year on year
- Free cash flow
- -$120.55M+41.18%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.